Detalles de la búsqueda
1.
Correction to: A phase I-II study of plerixafor in combination with fludarabine, idarubicin, cytarabine, and G-CSF (PLERIFLAG regimen) for the treatment of patients with the first early-relapsed or refractory acute myeloid leukemia.
Ann Hematol
; 97(5): 923, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29473097
2.
A phase I-II study of plerixafor in combination with fludarabine, idarubicin, cytarabine, and G-CSF (PLERIFLAG regimen) for the treatment of patients with the first early-relapsed or refractory acute myeloid leukemia.
Ann Hematol
; 97(5): 763-772, 2018 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-29392425
Resultados
1 -
2
de 2
1
Próxima >
>>